<DOC>
	<DOCNO>NCT00283725</DOCNO>
	<brief_summary>The purpose observational study examine pattern treatment care patient Alzheimer 's disease ( AD ) real-world arena examine association different outcome patient informal caregiver .</brief_summary>
	<brief_title>Use Different Treatment Care Methods Patients With Dementia Associated With Alzheimer 's Disease</brief_title>
	<detailed_description>This 2-year , multicenter , prospective ( look forward use periodic observation collect predominantly follow patient enrollment ) , longitudinal ( co relational research study involve repeat observation variable long period time ) , observational study . The objective study examine patient mild moderate AD currently treat different treatment care method real-world setting . Doctors provide medication ask treat patient particular treatment . The effect different management strategy cognition , activity daily live , behavior patient evaluate , data informal caregiver burden assess . Data utilization health social care service patient primary informal caregiver , include admission patient assist living facility nursing home assess . The doctor 's assessment clinical global impression adverse event also document . Data collect doctor baseline 6 , 12 , 24 month , caregiver baseline 6 , 12 , 18 , 24 month . The medication dosage administration base upon doctor ' prescription , individualized patient dictate protocol .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>Have physicianbased diagnosis mild moderate Alzheimer 's disease ( MiniMental State Examination [ MMSE ] score 1024 ) Must living home facility elderly ( eg , assist living ) , live frequent visit friend relative ( caregiver ) behavioral symptom ( eg , agitation wander ) Have plan change current treatment plan least 90 day Have use acetylcholinesterase inhibitor memantine currently use one past 30 day Must reside plan move nursing home within next 90 day patient participate another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Dementia</keyword>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Acetylcholinesterase inhibitor</keyword>
	<keyword>Galantamine</keyword>
	<keyword>Nursing Home Admission</keyword>
</DOC>